Manufacturers Life Insurance Company, The Reata Pharmaceuticals Inc Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$79.22 - $105.37 $411,072 - $546,764	5,189 Added 47.7%	16,068 $1.64 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $294,062 - $888,096	9,532 Added 87.62%	20,411 $1.86 Million
Q4 2022 Aug 11, 2023	SELL	$22.15 - $42.11 $5,803 - $11,032	-262 Reduced 2.35%	10,879 $413,000
Q4 2022 Feb 13, 2023	SELL	$22.15 - $42.11 $5,803 - $11,032	-262 Reduced 2.35%	10,879 $413,000
Q3 2022 Aug 11, 2023	SELL	$19.41 - $36.49 $1,494 - $2,809	-77 Reduced 0.69%	11,141 $279,000
Q3 2022 Nov 03, 2022	SELL	$19.41 - $36.49 $1,494 - $2,809	-77 Reduced 0.69%	11,141 $280,000
Q2 2022 Aug 11, 2023	SELL	$20.71 - $36.5 $4,514 - $7,957	-218 Reduced 1.91%	11,218 $340,000
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $4,514 - $7,957	-218 Reduced 1.91%	11,218 $341,000
Q1 2022 Aug 11, 2023	SELL	$24.12 - $39.6 $216,477 - $355,410	-8,975 Reduced 43.97%	11,436 $374,000
Q1 2022 May 20, 2022	SELL	$24.12 - $39.6 $67,077 - $110,127	-2,781 Reduced 19.56%	11,436 $375,000
Q4 2021 Feb 16, 2022	BUY	$25.61 - $110.96 $998 - $4,327	39 Added 0.28%	14,217 $375,000
Q3 2021 Nov 12, 2021	SELL	$100.0 - $143.02 $132,000 - $188,786	-1,320 Reduced 8.52%	14,178 $1.43 Million
Q2 2021 Aug 12, 2021	BUY	$78.27 - $151.29 $1.21 Million - $2.34 Million	15,498 New	15,498 $2.19 Million
Q2 2020 Aug 10, 2020	SELL	$126.3 - $176.56 $1.83 Million - $2.55 Million	-14,461 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $201,139 - $401,338	1,620 Added 12.62%	14,461 $2.09 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $9,246 - $27,022	124 Added 0.98%	12,841 $2.63 Million
Q3 2019 Nov 12, 2019	SELL	$71.26 - $95.75 $3,705 - $4,979	-52 Reduced 0.41%	12,717 $1.07 Million
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $13,834 - $16,794	178 Added 1.41%	12,769 $1.21 Million
Q1 2019 May 13, 2019	BUY	$51.9 - $101.79 $59,944 - $117,567	1,155 Added 10.1%	12,591 $1.08 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $76.44 $48,028 - $75,293	-985 Reduced 7.93%	11,436 $641,000
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $3,171 - $8,193	89 Added 0.72%	12,421 $1.02 Million
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $63,947 - $131,358	3,207 Added 35.15%	12,332 $431,000
Q1 2018 May 15, 2018	SELL	$20.0 - $30.19 $8,220 - $12,408	-411 Reduced 4.31%	9,125 $187,000
Q4 2017 Feb 08, 2018	BUY	$22.39 - $33.27 $10,836 - $16,102	484 Added 5.35%	9,536 $270,000
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $237,977 - $288,577	9,052	9,052 $282,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account